<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="182715-2018" EDITION="2018081"><TECHNICAL_SECTION><RECEPTION_ID>18-186837-001</RECEPTION_ID><DELETION_DATE>20180803</DELETION_DATE><FORM_LG_LIST>DE </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>81</NO_OJ><DATE_PUB>20180426</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 081-182715</NO_DOC_OJS><URI_LIST><URI_DOC LG="DE">http://ted.europa.eu/udl?uri=TED:NOTICE:182715-2018:TEXT:DE:HTML</URI_DOC></URI_LIST><LG_ORIG>DE</LG_ORIG><ISO_COUNTRY VALUE="DE"/><IA_URL_GENERAL>http://www.gwq-serviceplus.de</IA_URL_GENERAL><ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV><VALUES_LIST/><REF_NOTICE><NO_DOC_OJS>2016/S 072-125681</NO_DOC_OJS></REF_NOTICE></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180425</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="1">Open procedure</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Гepмaния</TI_CY><TI_TOWN>Дюселдорф</TI_TOWN><TI_TEXT>Фармацевтични продукти</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Německo</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Léčivé přípravky a zdravotnické prostředky</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Tyskland</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Lægemidler</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Deutschland</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Arzneimittel</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Γερμανία</TI_CY><TI_TOWN>Ντύσελντορφ</TI_TOWN><TI_TEXT>Φαρμακευτικά προϊόντα</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Germany</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Pharmaceutical products</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Alemania</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Productos farmacéuticos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Saksamaa</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Ravimid</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Saksa</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Farmaseuttiset tuotteet</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Allemagne</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Produits pharmaceutiques</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Ghearmáin, an</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Pharmaceutical products</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Njemačka</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Farmaceutski proizvodi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Németország</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Gyógyszerészeti termékek</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Germania</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Prodotti farmaceutici</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Vokietija, VFR</TI_CY><TI_TOWN>Diuseldorfas</TI_TOWN><TI_TEXT>Farmacijos produktai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Vācija</TI_CY><TI_TOWN>Diseldorfa</TI_TOWN><TI_TEXT>Farmācijas izstrādājumi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>il-Ġermanja</TI_CY><TI_TOWN>Dusseldorf</TI_TOWN><TI_TEXT>Prodotti farmaċewtiċi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Duitsland</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Farmaceutische producten</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Niemcy</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Produkty farmaceutyczne</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Alemanha</TI_CY><TI_TOWN>Dusseldorf</TI_TOWN><TI_TEXT>Produtos farmacêuticos</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Germania</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Produse farmaceutice</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Nemecko</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Farmaceutické výrobky</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Nemčija</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Farmacevtski proizvodi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Tyskland</TI_CY><TI_TOWN>Düsseldorf</TI_TOWN><TI_TEXT>Läkemedel</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="DE">GWQ ServicePlus AG</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="DE" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>GWQ ServicePlus AG</OFFICIALNAME></ORGANISATION><ADDRESS>GWQ ServicePlus AG, Tersteegenstraße 28, 40474 Düsseldorf, handelnd für die unter VI 3.) näher genannten Gesetzlichen Krankenkassen</ADDRESS><TOWN>Düsseldorf</TOWN><POSTAL_CODE>40474</POSTAL_CODE><COUNTRY VALUE="DE"/><PHONE>+49 211758498-0</PHONE><E_MAILS><E_MAIL>bieteranfrage@gwq-serviceplus.de</E_MAIL></E_MAILS><FAX>+49 211758498-48</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_GENERAL>http://www.gwq-serviceplus.de</URL_GENERAL></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="BODY_PUBLIC"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zu Fertigarzneimitteln mit demWirkstoff Adalimumab</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/><TYPE_SUPPLIES_CONTRACT VALUE="PURCHASE"/></TYPE_CONTRACT_LOCATION_W_PUB><NOTICE_INVOLVES_DESC><CONCLUSION_FRAMEWORK_AGREEMENT/></NOTICE_INVOLVES_DESC><SHORT_CONTRACT_DESCRIPTION><P>Die GWQ ServicePlus AG beabsichtigt nicht-exklusive Rabattvereinbarungen nach § 130a Abs. 8 SGBV zudem Wirkstoff Adalimumab zu schließen. Bis zum Start exklusiver Verträge im Zuge eines EU-weiten, offenen Vergabeverfahrens steht diese Vereinbarung allen Marktteilnehmern zum Beitritt offen. Aufgrund der Beachtung der Meldefristen ist der Betritt letztmalig zum 10.5.2018 möglich. Die Vertragsunterlagen, den Beschaffungsbedarf der teilnehmenden Krankenkassen sowie die Termine für die Meldung des Vertrages sind auf dem Vergabeportal der GWQ ServicePlus AG unter http://vergabeportal.gwq-serviceplus.de nach erfolgter Registrierung einzusehen und herunterzuladen.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33600000"/></CPV_MAIN></CPV></DESCRIPTION_AWARD_NOTICE_INFORMATION></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><PT_OPEN/></TYPE_OF_PROCEDURE_DEF><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3><PREVIOUS_PUBLICATION_EXISTS_F3><CNT_NOTICE_INFORMATION><CNT_NOTICE_INFORMATION_S CHOICE="CONTRACT_NOTICE"/><NOTICE_NUMBER_OJ>2016/S 072-125681</NOTICE_NUMBER_OJ><DATE_OJ><DAY>13</DAY><MONTH>04</MONTH><YEAR>2016</YEAR></DATE_OJ></CNT_NOTICE_INFORMATION><NO_OTHER_PREVIOUS_PUBLICATION/></PREVIOUS_PUBLICATION_EXISTS_F3></PREVIOUS_PUBLICATION_INFORMATION_NOTICE_F3></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_NUMBER>1</CONTRACT_NUMBER><LOT_NUMBER>1</LOT_NUMBER><CONTRACT_TITLE><P>Adalimumab</P></CONTRACT_TITLE><CONTRACT_AWARD_DATE><DAY>10</DAY><MONTH>04</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><OFFERS_RECEIVED_NUMBER>1</OFFERS_RECEIVED_NUMBER><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>kohlpharma GmbH</OFFICIALNAME></ORGANISATION><ADDRESS/><TOWN>Merzig</TOWN><COUNTRY VALUE="DE"/></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><ADDITIONAL_INFORMATION><P>Die GWQ handelt im Namen der folgenden gesetzlichen Krankenkassen:</P><P>Atlas BKK ahlmann;</P><P>Audi BKK;</P><P>BAHN-BKK;</P><P>Bertelsmann BKK;</P><P>BKK Aesculap;</P><P>BKK Akzo Nobel- Bayern;</P><P>BKK BPW Wiehl;</P><P>BKK Deutsche Bank AG;</P><P>BKK Diakonie;</P><P>BKK Die Bergische Krankenkasse;</P><P>BKK Duerkopp ADLER.</P><P>BKK Faber Castell &amp; Partner;</P><P>BKK firmus;</P><P>BKK Freudenberg;</P><P>BKK Groz-Beckert;</P><P>BKK HMR;</P><P>BKK KBA;</P><P>BKK MTU Friedrichshafen GmbH;</P><P>BKK Schwarzwald Baar Heuberg;</P><P>BKK Voralb;</P><P>BMW BKK;</P><P>Daimler BKK;</P><P>Die Schwenninger Betriebskrankenkasse;</P><P>E.ON BKK;</P><P>Heimat Krankenkasse;</P><P>IKK Brandenburg und Berlin;</P><P>IKK Nord;</P><P>IKK Südwest;</P><P>IKK gesund plus;</P><P>Krones BKK;</P><P>Merck BKK;</P><P>Salus BKK;</P><P>SBK;</P><P>SECURVITA Krankenkasse;</P><P>SKD BKK;</P><P>Südzucker BKK;</P><P>Wieland BKK.</P></ADDITIONAL_INFORMATION><NOTICE_DISPATCH_DATE><DAY>25</DAY><MONTH>04</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>